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Abstract. We successfully synthesized near infrared (NIR) sensitive Au(shell)-Au2S(core) 
nanoparticles, where Au2S dielectric core was encapsulated by a thin gold shell. The cytotoxicity in 
vitro and biodistribution in vivo of Au-Au2S nanoparticles was studied by using NIH3T3 cells and 
KM mice, respectively. The quantitative analysis of Au in each tissue of mice was done by using the 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Au-Au2S nanoparticles (< 300 µg/ml) 
showed good biocompatibility. Au-Au2S nanoparticles were preferentially taken up by the liver and 
spleen, and ultimately eliminated mostly in the feces. 
Introduction 
A major goal of nanotechnology
 
is to develop materials with the functional properties. One 
approach
 
has been to construct materials from nanoscale hybrids. A number of reports on the 
synthesis of Au-based nanoscale hybrid systems can be found in literature [1-5], because gold has 
unique applications in many areas such as drug delivery [1], immunoassay labeling [2], nonlinear 
optical switching,
 
and Raman spectroscopy enhancement [3]. We have recently synthesized a new 
kind of NIR sensitive nanoparticles composed of Au and Au2S, where Au2S dielectric core was 
encapsulated by a thin gold shell [4, 5]. The surface that the Au-Au2S nanoparticles present to the 
environment is a contiguous layer of gold. Gold is essentially a bioinert material and has been found 
to be useful in fields ranging from dental surgery to arthritis treatments [6], Hence, the gold shell 
surrounding Au-Au2S nanoparticles should also take advantage of the inherent biocompatibility of 
gold, not requiring further surface functionalization or protective layer growth. The most unique 
feature of Au-Au2S nanoparticles is that their plasmon resonance (wavelength of optimal optical 
extinction) can be designed to fall in the near infrared (NIR) region [7]. The near-infrared (NIR) 
light in controlled doses has been used for medical applications, because it is non-destructive 
property to human tissues. In the previous report, Ren et al. absorbed an anti-tumor drug, cis-platin, 
onto the surface of Au–Au2S nanoparticles successfully, which exhibited the possible clinic 
application of these potential drug delivery carriers [8]. In this paper, the biocompatibility in vitro 
and biodistribution in vivo of Au-Au2S nanoparticles were studied by using NIH3T3 cells and Kun 
Ming (KM) mice, respectively. 
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Materials and methods 
Preparation and characterization of Au-Au2S nanoparticles. Following the reference [8], the 
growth of Au–Au2S nanoparticles was initiated when aqueous solutions of HAuCl4 (provided by 
Acrobs Organics) and Na2S (obtained from Sigma) were mixed. Briefly, 20 ml of 1 mM Na2S was 
mixed with 20 ml of 2 mM HAuCl4, and stored at 25ºC for 1 day. Sample for UV–Vis study were 
placed in quartz crystal cuvettes, and the absorption spectra were acquired at room temperature 
using a UV-2550 spectrophotometer (Shimadzu). Samples for TEM were prepared by placing a 
drop of solution onto carbon-coated copper grids and left to dry prior to investigation using a TEM 
microscope (100kV, Hitachi H600).  
Cytotoxicity assay. We used the colorimetric methyl-thiazol-tetrazolium (MTT) assay to study cell 
survival after incubation with NIH3T3 cell. Briefly, Cells were seeded at 1×10
4
 cells/well in a 
96-well plate and incubated at 37ºC in 5% CO2 for 24h. The medium was then removed and 
replaced with fresh medium containing Au-Au2S nanoparticles at various concentrations ranging 
from 0 to 600 µg/ml (100 µl/well). Cells treated with medium only as negative control group. 
Incubations were made for 24 and 72 h before removal of media containing Au-Au2S nanoparticles. 
20 µl MTT (5 mg/ml in PBS) was added to each well and then the plate was further incubated for 4 
h under normal growing conditions. All remaining supernatant were removed and 150 µl DMSO 
was added to each well. Plates were then incubated for 30 min at 37°C to ensure all crystals were 
dissolved. Finally, the absorbance at 490 nm for each well was measured on a microreader (Bio-tek 
ELX800). Cell survival at each dose was calculated relative to the negative control group. Every 









Biodistribution in vivo. KM male mice (provided by Anti-Cancer Research Center, Xiamen 
University), aged 7 weeks and weighing 18-21 g, were used in the experiments. After filtration 
through 0.22 µm filter membrane, 200 µl nanoparticles solution (1 mg/ml) was injected into a KM 
mouse via the tail vein. All animal experiments were performed in compliance with the local ethics 
committee. At 30 min, 1h, 12h, 24h, and 7d, blood, muscle (left thigh), bone (left femur with 
marrow), heart, liver, spleen, lung, kidney, brain of KM mice were collected. Except the blood, 
every sample was washed thoroughly with deionized water and dried for 4 hours at 120ºC [9]. In 
order to prepare ICP solution, the samples were digested by a microwave accelerated reaction 
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Fig. 2 UV– vis spectrum of Au–Au2S 
nanopaiticles 
Fig. 1 TEM image of Au-Au2S nanoparticles 
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qualitative analyzed for Au by using a Inductively Coupled Plasma Mass Spectrometry (ICP-MS, 
Perkin Elmer SCIEX ELAN DRC-e). 10 ppb Au aqueous solution (purchased from National 
Research Center for CRM’S) was used as the standard control. Every sample was repeated 5 times. 
Results and discussion 
Characterization of Au-Au2S nanoparticles. Fig. 1 illustrated a typical TEM image of Au-Au2S 
nanoparticles. The spherical particles were about 55 nm in diameter. Fig. 2 displayed a UV–Vis 
spectrum of Au–Au2S nanoparticles which consisted of two absorption bands. The band I at 520 nm 
was assigned to the surface-plasmon resonance of the Au nanoparticles, whereas the band II at 760 
nm was due to Au-coated Au2S nanoparticles [8]. 
 
Cytotoxicity of Au-Au2S nanoparticles. Initial 
studies were performed to examine the 
cytotoxicity of the Au-Au2S nanoparticles in 
NIH3T3 cells. As shown in Fig. 3, the cellular 
viability depended on the concentration, namely 
increasing Au-Au2S nanoparticles resulted in a 
decrease of cell viability. The concentration 
inhibited cell growth by 50% (IC50) was reached 
300 µg/ml.  As the concentration < 300 µg/ml, 
no toxicity was found even up to 3 days culture, 
indicating the expose time with Au-Au2S 
nanoparticles has little effect on the cytotoxicity. 
Thus, it may be concluded that the Au-Au2S 
nanoparticles with concentration < 300 µg/ml are 
biocompatible and can be used as drug carrier 
without causing cytotoxicity. 
Biodistribution of Au-Au2S nanoparticles. 
Since the male mice exhibit more severe toxic 
symptoms for nanoparticles than the females 
[10], we chose male KM mice in our 
experiments.  The concentration of Au in each 
tissue was determined by ICP-MS. No gold was 
found in blood, bone, muscle, heart and brain. 
Most of Au deposited in the liver, spleen, and 
little in kidney and lung, which decreased 
slightly with increasing times. This was 
consistent with Yoshifumi’s observation that 
nanoscale substances may be easily taken up by 
the reticuloendotheliar system (RES) [11]. 
We calculated the amount of remained 
Au-Au2S in the mice as shown in Fig. 5. By 
increasing the time from 30 min to 7 days, the 
remained Au-Au2S decreased from 14.1% to 7.4%. We also found some gold in the urine of mice 
after injection up to 7 days, indicating those particles may be expelled through from the body in 
















































Fig. 3 Cytotoxicity of Au-Au2S 
nanoparticles  
Fig. 4 Biodistribution of Au-Au2S 
nanoparticles in mice up to 7 days of injection 






















Injection Time (hr) 
changes in each organ due to Au-Au2S nanoparticles’ deposition, we examined the histological 
sections of tissues. No pathological changes were found in each organ such as liver, spleen, lung, 
and kidney and so on, which showed similar 
to the control group (pictures not showed 
here). Hence, Au-Au2S nanoparticles may 
possess good bio-safety. 
Conclusions  
We successfully synthesized near infrared 
(NIR) sensitive Au(shell)-Au2S(core) 
nanoparticles, where Au2S dielectric core was 
encapsulated by a thin gold shell. Au-Au2S 
nanoparticles were preferentially taken up by 
the liver and spleen and ultimately eliminated 
mostly in the feces. The biodistribution 
examinations revealed that liver, spleen, 
kidney and lung are the target organs for 
Au-Au2S nanoparticles. Considering the 
cytotoxicity assays and pathological examinations, 
they appear to be potential drug delivery vectors 
in future. 
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Fig. 5   The amount of the remained 
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